Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute as a Breast Medical Oncologist

  • By

  • September 3, 2026

  • 2 min

Share

Clinical Report: Kriti Ahuja, M.D., Joins Baptist Health Wertheim Cancer Institute

Overview

Baptist Health Wertheim Cancer Institute has welcomed Kriti Ahuja, M.D., a board-certified medical oncologist specializing in breast cancer. Dr. Ahuja's clinical focus includes comprehensive treatment for breast malignancies.

Background

The integration of specialized oncologists like Dr. Ahuja into cancer care teams is essential for advancing treatment options for patients with breast cancer.

Data Highlights

No numerical or trial data available in the source material.

Key Findings

  • Dr. Ahuja specializes in the comprehensive treatment of breast malignancies.
  • She has a strong background in oncology research, with numerous peer-reviewed publications.
  • Dr. Ahuja is fluent in English and Hindi, enhancing patient communication.
  • She is an active member of the American Society of Clinical Oncology and the American Society of Hematology.
  • Her training includes a fellowship at Roswell Park Comprehensive Cancer Center.

Clinical Implications

Dr. Ahuja's addition to the Baptist Health Wertheim Cancer Institute enhances the institution's capacity to provide specialized care for breast cancer patients.

Conclusion

Dr. Ahuja's expertise will be an asset to the Baptist Health Wertheim Cancer Institute.

Related Resources & Content

  1. Baptist Health South Florida, Source, Year -- Kyaw Aung, M.B.B.S., Ph.D., Joins Baptist Health Miami Cancer Institute
  2. The ASCO Post, Source, Year -- Kristen Whitaker, MD, Joins Fox Chase Department of Clinical Genetics
  3. Baptist Health South Florida, Source, Year -- Spencer Streit, D.O., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist and Hematologist
  4. Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
  5. The ASCO Post — Breast Care Services at Henry Ford Health System Gains New Director, Three New Surgeons
  6. Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
  7. Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer | New England Journal of Medicine
  8. Endocrine and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer—Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update | Journal of Clinical Oncology

Original Source(s)

Related Content